Developing new methods for creating drugs using light-driven chemical reactions
Bioinspired selective heterogeneous organic photoredox catalysis
This study is exploring a new way to make medicines using light to help create better and safer drugs for patients, making it easier to produce the complex compounds needed for effective treatments.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Southern Illinois University Carbondale NIH-funded |
| Lab location | 1 site (Carbondale, United States) |
| Project ID | NIH-11036485 on NIH RePORTER |
What this research studies
This research focuses on innovative chemical reactions that utilize light to create new drugs, specifically through a process called photoredox catalysis. By employing unique materials known as porous crystalline molecular frameworks, the project aims to overcome challenges in drug synthesis related to efficiency and selectivity. The approach seeks to enhance the way chemical reactions occur at a molecular level, making it easier to produce complex drug compounds that are essential for medical treatments. Patients may benefit from the development of new medications that are more effective and have fewer side effects.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who may benefit from new drug therapies, particularly those with conditions that current medications do not adequately address.
Not a fit: Patients who are not seeking new drug therapies or who have conditions that are already well-managed by existing medications may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the discovery of new drugs that are more effective and easier to produce.
How similar studies have performed: While photoredox catalysis is a growing field, this specific approach using porous crystalline frameworks is relatively novel and has not been extensively tested in prior research.
Where this research is happening
Carbondale, United States
- Southern Illinois University Carbondale — Carbondale, United States (Active)
Researchers
- Principal investigator: Deria, Pravas — Southern Illinois University Carbondale
- Study coordinator: Deria, Pravas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.